BLOCK® cooperation with Institute Hematology in Praque
The Institute of Hematology and Blood Transfusion and BLOCK® concluded a Memorandum of Cooperation. On Monday 26 November, the Director of the Institute of Hematology and Blood Transfusion in Prague (UHKT) and the Chairman of the BLOCK® Board of Directors signed a memorandum of cooperation. By signing the Memorandum, cooperation was initiated between the two entities in the field of development and production of modern gene therapy medicinal products. Both UHKT and BLOCK® share a common view of the high technology requirements for production facilities for the research, development and production of immunotherapeutic medicinal products containing live cells.
The primary objective is to focus on new clean room technologies. To meet the objectives of the Memorandum, the Institute will have access to new manufacturing technologies that will enable the production of immunotherapeutical products (especially gene therapy) for patients of the institute and BLOCK® to improve existing insulators to meet the demanding requirements for human tissue and cell processing and advanced the production of modern gene therapy medicinal products.